{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:12:25Z","timestamp":1777497145052,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12072-024-10733-y","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T12:15:59Z","timestamp":1730290559000},"page":"244-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3574-0714","authenticated-orcid":false,"given":"Shiva","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songhua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5341-7286","authenticated-orcid":false,"given":"Jesse D.","family":"Schold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"10733_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15678","author":"AK Israni","year":"2020","unstructured":"Israni AK, Zaun D, Hadley N, et al. OPTN\/SRTR 2018 annual data report: deceased organ donation. Am J Transplant. 2020;20 Suppl 1:509\u201341. https:\/\/doi.org\/10.1111\/ajt.15678","journal-title":"Am J Transplant"},{"key":"10733_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, et al. AASLD Practice Guideline: Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660\u201378.","journal-title":"Hepatology"},{"key":"10733_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24496","author":"FD Gordon","year":"2016","unstructured":"Gordon FD, Goldberg DS, Goodrich NP, et al. Recurrent primary sclerosing cholangitis in the adult-to-adult living donor liver transplantation cohort study: comparison of risk factors between living and deceased donor recipients. Liver Transplant. 2016;22(9):1214\u201322. https:\/\/doi.org\/10.1002\/lt.24496","journal-title":"Liver Transplant"},{"key":"10733_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.09.010","author":"JK Dyson","year":"2015","unstructured":"Dyson JK, Webb G, Hirschfield GM, et al. Unmet clinical need in autoimmune liver diseases. J Hepatol. 2015;62(1):208\u201318. https:\/\/doi.org\/10.1016\/j.jhep.2014.09.010","journal-title":"J Hepatol"},{"key":"10733_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03969.x","author":"D Goldberg","year":"2012","unstructured":"Goldberg D, Bittermann T, Makar G. Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis. Am J Transplant. 2012;12(6):1603\u20139. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03969.x","journal-title":"Am J Transplant"},{"key":"10733_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31821694b3","author":"DS Goldberg","year":"2011","unstructured":"Goldberg DS, French B, Thomasson A, Reddy KR, Halpern SD. Current trends in living donor liver transplantation for primary sclerosing cholangitis. Transplantation. 2011;91(10):1148\u201352. https:\/\/doi.org\/10.1097\/TP.0b013e31821694b3","journal-title":"Transplantation"},{"key":"10733_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03402.x","author":"H Egawa","year":"2011","unstructured":"Egawa H, Ueda Y, Ichida T, et al. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry. Am J Transplant. 2011;11(3):518\u201327. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03402.x","journal-title":"Am J Transplant"},{"key":"10733_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27307","author":"DS Goldberg","year":"2014","unstructured":"Goldberg DS, French B, Abt PL, Olthoff K, Shaked A. Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology. 2014;60(5):1717\u201326. https:\/\/doi.org\/10.1002\/hep.27307","journal-title":"Hepatology"},{"key":"10733_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23547","author":"ES Orman","year":"2013","unstructured":"Orman ES, Barritt AS, Wheeler SB, Hayashi PH. Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transplant. 2013;19(1):59\u201368. https:\/\/doi.org\/10.1002\/lt.23547","journal-title":"Liver Transplant"},{"issue":"4","key":"10733_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/SLA.0b013e3182104784","volume":"253","author":"DP Foley","year":"2011","unstructured":"Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011;253(4):817\u201325. https:\/\/doi.org\/10.1097\/SLA.0b013e3182104784","journal-title":"Ann Surg"},{"key":"10733_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24350","author":"T Hildebrand","year":"2016","unstructured":"Hildebrand T, Pannicke N, Dechene A, et al. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis. Liver Transplant. 2016;22(1):42\u201352. https:\/\/doi.org\/10.1002\/lt.24350","journal-title":"Liver Transplant"},{"issue":"5","key":"10733_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/TP.0000000000000447","volume":"99","author":"V Sundaram","year":"2015","unstructured":"Sundaram V, Choi G, Jeon CY, et al. Donation after cardiac death liver transplantation in primary sclerosing cholangitis. Transplantation. 2015;99(5):973\u20138. https:\/\/doi.org\/10.1097\/TP.0000000000000447","journal-title":"Transplantation"},{"key":"10733_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.06.027","author":"PJ Trivedi","year":"2017","unstructured":"Trivedi PJ, Scalera I, Slaney E, et al. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis. J Hepatol. 2017;67(5):957\u201365. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.027","journal-title":"J Hepatol"},{"key":"10733_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s40472-020-00283-1","author":"KP Croome","year":"2020","unstructured":"Croome KP, Taner CB. The changing landscapes in DCD liver transplantation. Curr Transplant Rep. 2020;7:194\u2013204. https:\/\/doi.org\/10.1007\/s40472-020-00283-1","journal-title":"Curr Transplant Rep"},{"key":"10733_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2013.01.002","author":"S Leppke","year":"2013","unstructured":"Leppke S, Leighton T, Zaun D, et al. Scientific registry of transplant recipients: collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev. 2013;27(2):50\u20136. https:\/\/doi.org\/10.1016\/j.trre.2013.01.002","journal-title":"Transplant Rev"},{"key":"10733_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01395.x","author":"S Tamura","year":"2007","unstructured":"Tamura S, Sugawara Y, Kaneko J, Matsui Y, Togashi J, Makuuchi M. Recurrence of primary sclerosing cholangitis after living donor liver transplantation. Liver Int. 2007;27(1):86\u201394. https:\/\/doi.org\/10.1111\/j.1478-3231.2006.01395.x","journal-title":"Liver Int"},{"key":"10733_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00245.x","author":"H Haga","year":"2007","unstructured":"Haga H, Miyagawa-Hayashino A, Taira K, et al. Histological recurrence of autoimmune liver diseases after living-donor liver transplantation. Hepatol Res. 2007;37(s3):S463\u20139. https:\/\/doi.org\/10.1111\/j.1872-034X.2007.00245.x","journal-title":"Hepatol Res"},{"key":"10733_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-010-1256-1","author":"R Kashyap","year":"2010","unstructured":"Kashyap R, Safadjou S, Chen R, et al. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases-an analysis of the UNOS database. J Gastrointest Surg. 2010;14(9):1362\u20139. https:\/\/doi.org\/10.1007\/s11605-010-1256-1","journal-title":"J Gastrointest Surg"},{"key":"10733_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13828","author":"AD Aravinthan","year":"2016","unstructured":"Aravinthan AD, Doyle AC, Issachar A, et al. First-degree living-related donor liver transplantation in autoimmune liver diseases. Am J Transplant. 2016;16(12):3512\u201321. https:\/\/doi.org\/10.1111\/ajt.13828","journal-title":"Am J Transplant"},{"key":"10733_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16864","author":"M Heinemann","year":"2022","unstructured":"Heinemann M, Liwinski T, Adam R, et al. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: experience from the European liver transplant registry. Am J Transplant. 2022;22(2):626\u201333. https:\/\/doi.org\/10.1111\/ajt.16864","journal-title":"Am J Transplant"},{"issue":"8","key":"10733_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/lt.24449","volume":"22","author":"JJ Blok","year":"2016","unstructured":"Blok JJ, Detry O, Putter H, et al. Longterm results of liver transplantation from donation after circulatory death. Liver Transplant. 2016;22(8):1107\u201314. https:\/\/doi.org\/10.1002\/lt.24449","journal-title":"Liver Transplant"},{"issue":"4","key":"10733_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1600-6143.2006.01243.x","volume":"6","author":"R Mateo","year":"2006","unstructured":"Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN\/UNOS data. Am J Transplant. 2006;6(4):791\u20136. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01243.x","journal-title":"Am J Transplant"},{"key":"10733_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7043","author":"J Dubbeld","year":"2010","unstructured":"Dubbeld J, Hoekstra H, Farid W, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg. 2010;97(5):744\u201353. https:\/\/doi.org\/10.1002\/bjs.7043","journal-title":"Br J Surg"},{"key":"10733_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.12.033","author":"R Taylor","year":"2019","unstructured":"Taylor R, Allen E, Richards JA, et al. Survival advantage for patients accepting the offer of a circulatory death liver transplant. J Hepatol. 2019;70(5):855\u201365. https:\/\/doi.org\/10.1016\/j.jhep.2018.12.033","journal-title":"J Hepatol"},{"key":"10733_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/AJT.15276","author":"WR Kim","year":"2019","unstructured":"Kim WR, Lake JR, Smith JM, et al. OPTN\/SRTR 2017 annual data report: liver. Am J Transplant. 2019;19 Suppl 2:184\u2013283. https:\/\/doi.org\/10.1111\/AJT.15276","journal-title":"Am J Transplant"},{"key":"10733_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21679","author":"E Alabraba","year":"2009","unstructured":"Alabraba E, Nightingale P, Gunson B, et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transplant. 2009;15(3):330\u201340. https:\/\/doi.org\/10.1002\/lt.21679","journal-title":"Liver Transplant"},{"key":"10733_CR27","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2020.0387","author":"VA Fleetwood","year":"2021","unstructured":"Fleetwood VA, Janek K, Leverson G, et al. Predicting the safe use of deceased after circulatory death liver allografts in primary sclerosing cholangitis. Exp Clin Transplant. 2021;19(6):563\u201369. https:\/\/doi.org\/10.6002\/ect.2020.0387","journal-title":"Exp Clin Transplant"},{"key":"10733_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002194","author":"T Kubota","year":"2018","unstructured":"Kubota T, Hata K, Sozu T, et al. Impact of donor age on recipient survival in adult-to-adult living-donor liver transplantation. Ann Surg. 2018;267(6):1126\u201333. https:\/\/doi.org\/10.1097\/SLA.0000000000002194","journal-title":"Ann Surg"},{"key":"10733_CR29","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/TP.0000000000003542","volume":"105","author":"M Berenguer","year":"2020","unstructured":"Berenguer M, Di Maira T, Baumann U, et al. Characteristics, trends and outcomes of liver transplantation for primary sclerosing cholangitis in female vs male patients: an analysis from the European liver transplant registry. Transplantation. 2021;105(10):2255\u201362. https:\/\/doi.org\/10.1097\/TP.0000000000003542","journal-title":"Transplantation"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10733-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:45:18Z","timestamp":1740210318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10733-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10733"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10733-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4780596\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant\u00a0conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.\u00a0This article does not contain any studies with animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}